CXCL13 and neoplasm: The majority of signature-based approaches rely on gene set enrichment analysis of clustered tumor-reactive T cells, and thus identify genes that are upregulated in the CXCL13 expressing cluster that we have previously shown to contain tumor-reactive infiltrating T cells15.